Key Takeaways

• SXTP has climbed from roughly $0.85 to the mid-$1.40s over recent sessions, showing a short-term uptrend with sharp intraday swings.
• 60 Degrees Pharmaceuticals Inc. posts about $1.0M in annual revenue but runs steep losses, with deeply negative profit margins and heavy cash burn.
• SXTP holds just over $1.0M in cash and maintains a current ratio above 2.0, signaling near-term liquidity but limited long-term cushion.
• Intraday SXTP trading shows repeated spikes above $1.50 followed by quick fades, a pattern momentum traders watch for scalps and potential breakouts.